Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$457M |
| 2 |
Ameriprise Financial
AMP
|
+$406M |
| 3 |
Salesforce
CRM
|
+$299M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$291M |
| 5 |
Halliburton
HAL
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$323M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$294M |
| 3 |
Citizens Financial Group
CFG
|
+$280M |
| 4 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$269M |
| 5 |
McDonald's
MCD
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8% |
| 2 | Consumer Discretionary | 7.85% |
| 3 | Industrials | 7.53% |
| 4 | Energy | 7.35% |
| 5 | Technology | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RESI
7076
CALL
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $88K | ﹤0.01% |
5,200
-10,500
| -67% | -$198K |
|
7077
Akebia Therapeutics
AKBA
$242M
| $87K | ﹤0.01% |
+8,462
| New | +$72.2K |
|
7078
Cimpress
CMPR
$2.3B
| $87K | ﹤0.01% |
1,030
-20,099
| -95% | -$1.72M |
|
7079
CALL
Dolby
DLB
$5.84B
| $87K | ﹤0.01% |
2,200
-6,100
| -73% | -$242K |
|
7080
Madrigal Pharmaceuticals
MDGL
$11.7B
| $87K | ﹤0.01% |
1,118
-4,938
| -82% | -$414K |
|
7081
PUT
Monro
MNRO
$359M
| $87K | ﹤0.01% |
+1,400
| New | +$87.3K |
|
7082
PUT
Piper Sandler
PIPR
$5.41B
| $87K | ﹤0.01% |
8,000
-4,000
| -33% | -$49.9K |
|
7083
PUT
Regal Rexnord
RRX
$11.7B
| $87K | ﹤0.01% |
1,200
-200
| -14% | -$15.5K |
|
7084
PUT
Theravance Biopharma
TBPH
$881M
| $87K | ﹤0.01% |
6,700
+5,100
| +319% | +$79.1K |
|
|
CPE
7085
DELISTED
Callon Petroleum Company
CPE
| $87K | ﹤0.01% |
1,046
-6,693
| -86% | -$555K |
|
|
NXTM
7086
CALL
DELISTED
NxStage Medical Inc.
NXTM
| $87K | ﹤0.01% |
+6,100
| New | +$103K |
|
|
ITC
7087
PUT
DELISTED
ITC HOLDINGS CORP
ITC
| $87K | ﹤0.01% |
2,700
-2,600
| -49% | -$90.6K |
|
|
BEAT
7088
PUT
DELISTED
BioTelemetry, Inc.
BEAT
| $87K | ﹤0.01% |
9,200
-300
| -3% | -$2.78K |
|
7089
American Superconductor
AMSC
$1.55B
| $86K | ﹤0.01% |
+16,442
| New | +$109K |
|
7090
PUT
CNO Financial Group
CNO
$5.11B
| $86K | ﹤0.01% |
4,700
+2,200
| +88% | +$39.9K |
|
7091
CALL
Enova International
ENVA
$6.61B
| $86K | ﹤0.01% |
4,600
+3,900
| +557% | +$75.8K |
|
7092
iShares MSCI Malaysia ETF
EWM
$330M
| $86K | ﹤0.01% |
1,784
+157
| +10% | +$8.29K |
|
7093
PUT
Hovnanian Enterprises
HOV
$785M
| $86K | ﹤0.01% |
1,292
-1,692
| -57% | -$133K |
|
7094
CALL
Moelis & Co
MC
$5.07B
| $86K | ﹤0.01% |
3,000
+2,200
| +275% | +$64.3K |
|
7095
RB Global
RBA
$15.6B
| $86K | ﹤0.01% |
3,078
-1,788,631
| -100% | -$49.1M |
|
7096
PUT
Travere Therapeutics
TVTX
$5.86B
| $86K | ﹤0.01% |
2,600
-7,300
| -74% | -$200K |
|
7097
CALL
CVR Partners
UAN
$1.31B
| $86K | ﹤0.01% |
680
-580
| -46% | -$79.3K |
|
|
NM
7098
PUT
DELISTED
Navios Maritime Holdings Inc.
NM
| $86K | ﹤0.01% |
2,300
+1,180
| +105% | +$44.6K |
|
|
PRTK
7099
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $86K | ﹤0.01% |
+3,319
| New | +$94.2K |
|
|
AERI
7100
DELISTED
Aerie Pharmaceuticals
AERI
| $86K | ﹤0.01% |
+4,851
| New | +$88.9K |
|
Similar funds
Ken Griffin's Q2 2015 Portfolio in Review
As of Q2 2015, Ken Griffin held 9,571 positions worth $115B, up 9.3% from $106B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ken Griffin deployed $5.11B of net new capital in Q2 2015, opening 1,066 new positions and adding to 4,008 existing holdings. Its largest new stake was Macy's: 3,207,474 shares worth $216M.
By sector, the portfolio is most concentrated in Financials at 8% of assets, up from 7.9% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Dollar General, an estimated $323M trimmed.
- Ken Griffin's largest Q2 2015 buy was Macy's: 3,207,474 shares worth $216M.
- Ken Griffin added most to Chubb in Q2 2015, an estimated $457M increase.
- Ken Griffin's biggest Q2 2015 reduction was Dollar General, cutting an estimated $323M.
- Ken Griffin fully exited Citizens Financial Group in Q2 2015, selling an estimated $280M.
- Ken Griffin's ten largest holdings make up 15% of its $115B portfolio in Q2 2015.
- Ken Griffin opened 1,066 new positions and closed 872 in Q2 2015.
- Ken Griffin's portfolio value rose 9.3% quarter-over-quarter to $115B.
Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.